General Information

Age Group

Adults

Status

Active

Protocol Number

09DY-02-21A01-01

Background Information

The purpose of this research is to collect blood specimens to evaluate a new diagnostic blood test that will help physicians diagnose individuals that may have new symptoms of heart failure or to determine the severity in those with heart failure, better than they can today. Your sample will be used to evaluate the usefulness and clinical utility of cardiac markers, specifically NT-proBNP in patients with heart failure. The new test being evaluated is investigational and not approved by the Food and Drug Administration (FDA).

Offered At

Inova Fairfax Hospital
3300 Gallows Rd.
Falls Church, VA 22042
Principal Investigator

Christopher deFilippi, MD

Eligibility Information

Subjects presenting with signs or symptoms consistent with a clinical suspicion of new onset or acute exacerbation of heart failure.

Ineligibility Information

  • Severe renal insufficiency (Stage 4 and 5 CKD; eGFR < 30 mL/min/1.73m2) requiring dialysis.
  • Dyspnea after chest trauma.
  • Prior participation in this study or current participation in an investigational drug study (with the exception of other IVD blood tests)